Christodoulopoulou Vasiliki, Trakakis Eftihios, Pergialiotis Vasilios, Peppa Melpomeni, Chrelias Charalampos, Kassanos Dimitrios, Papantoniou Nikolaos
3rd Department of Obstetrics and Gynaecology, Attiko Hospital, National and Kapodistrian University of Athens, Athens, Greece.
2nd Department of Internal Medicine, Research Institute and Diabetes Center, Athens University Medical School, Attikon University Hospital, Athens, Greece.
J Family Reprod Health. 2016 Dec;10(4):184-190.
The purpose of the present study was to examine the impact of menstrual cycle abnormalities among patients with polycystic ovary syndrome (PCOS) on biochemical and anthropometric characteristics. We conducted a prospective observational study of patients 17-35 years of age with PCOS that attended the department of Gynecological Endocrinology of our hospital. A total of 309 women with PCOS participated in the study. In total, 72.2% suffered from menstrual cycle disorders. In our study 15.1% of women were overweight and 24% were obese. Also, 36% of the sample had androgenetic alopecia and 56.4% had acne. According to the stepwise discriminant analysis, we observed that glucose displayed the strongest association to the menstrual status (F to eliminate = 14.13), followed by endometrial thickness (F to eliminate = 10.89), waist circumference (F to eliminate = 10.17), LH levels (F to eliminate = 8.15) and PRL (F to eliminate = 4.45). Significantly higher levels of LH and TSH and lower levels of prolactin were found in women with menstrual disorders compared to those with normal menstrual cycles. Fasting glucose was also considerably higher among these patients although markers of insulin resistance such as the Matsuda, Quicki and HOMA-IR indices did not differ. According to the findings of our study PCOS patients with menstrual disorders exhibit hormonal alterations and elevated fasting glucose. Future studies are needed in this field to corroborate our findings and determine the anthropometric and biochemical profile of patients with menstrual cycle irregularities.
本研究的目的是探讨多囊卵巢综合征(PCOS)患者月经周期异常对生化和人体测量学特征的影响。我们对我院妇科内分泌科就诊的17 - 35岁PCOS患者进行了一项前瞻性观察研究。共有309名PCOS女性参与了该研究。总体而言,72.2%的患者存在月经周期紊乱。在我们的研究中,15.1%的女性超重,24%的女性肥胖。此外,36%的样本有雄激素性脱发,56.4%的样本有痤疮。根据逐步判别分析,我们观察到血糖与月经状态的关联最强(剔除F值 = 14.13),其次是子宫内膜厚度(剔除F值 = 10.89)、腰围(剔除F值 = 10.17)、促黄体生成素(LH)水平(剔除F值 = 8.15)和催乳素(PRL)(剔除F值 = 4.45)。与月经周期正常的女性相比,月经紊乱的女性LH和促甲状腺激素(TSH)水平显著升高,催乳素水平降低。这些患者的空腹血糖也明显更高,尽管诸如松田、奎基和稳态模型评估胰岛素抵抗(HOMA - IR)指数等胰岛素抵抗指标并无差异。根据我们的研究结果,月经紊乱的PCOS患者存在激素改变和空腹血糖升高的情况。该领域需要进一步的研究来证实我们的发现,并确定月经周期不规律患者的人体测量学和生化特征。